Lv1
48 积分 2024-09-28 加入
Pharmacological inhibition of DUSP6 suppresses gastric cancer growth and metastasis and overcomes cisplatin resistance
2个月前
已完结
PI3K/Akt/mTOR: A promising therapeutic target for non-medullary thyroid carcinoma
4个月前
已完结
Genomic alterations in thyroid cancer: biological and clinical insights
4个月前
已完结
FGFR3 Destabilizes PD-L1 Via NEDD4 to Control T Cell-Mediated Bladder Cancer Immune Surveillance
4个月前
已完结
Genomic alterations in thyroid cancer: biological and clinical insights
4个月前
已完结
Current Insights and Barriers in FGFR-Mediated Signaling in Lung Cancer
5个月前
已完结
FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions
5个月前
已完结
Discovery of a Selective and Orally Bioavailable FGFR2 Degrader for Treating Gastric Cancer
5个月前
已完结
Small-Molecule FGFR-Targeted Medicinal Chemistry: Advances Since 2020 and Future Perspectives
5个月前
已完结
Unleashing the potential of combining FGFR inhibitor and immune checkpoint blockade for FGF/FGFR signaling in tumor microenvironment
6个月前
已完结
皖公网安备34019202002308
